US OptionsDetailed Quotes

IBRX241220P2000

Watchlist

0.04
0.000.00%

15min DelayTrading Oct 25 12:06 ET

0.00High0.00Low

ImmunityBio Stock Discussion

Moomoo Recap US

Dec 11 15:29

Columns Nasdaq Surges Past 20,000 for the First Time, Powered by Tech Giants | Wall Street Today

The $Nasdaq Composite Index (.IXIC.US)$ hit a record intraday and closing high Wednesday, crossing 20,000 points for the first time. The index was up 1.8% at 20,050 in late trading, finishing 1.77% higher. The $S&P 500 Index (.SPX.US)$ closed just below its highest close on record at 6,090.27, while the $Dow Jones Industrial Average (.DJI.US)$ fell 0.2%.
MACRO
In economic news, November’s consumer price index (C...

Weekly Buzz

TrendTrader

Nov 22 10:48

Nice curl 👀

$ImmunityBio (IBRX.US)$

Stock_Drift

Nov 21 09:10

$ImmunityBio (IBRX.US)$

Trytosaveabit

Nov 19 13:31

Update

$ImmunityBio (IBRX.US)$ ImmunityBio Completes ANKTIVA's Post-Approval Enrollment Of The 100th Patient In BCG Unresponsive NMIBC CIS Trial And Reports A Complete Response Rate Of 71% With A Durable Duration Of Response Ranging Up To 54 Months Reported For 82 Patients Published In NEJM
High responder rate associated with a duration of response ranging as long as 54 months in QUILT-3.032 with 100 patients enrolledUpdated data intended to be submitted as part of a European Medicines Agency (EMA...